{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:08:38Z","timestamp":1749701318101,"version":"3.41.0"},"reference-count":55,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2025.1998","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:39:58Z","timestamp":1747741198000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Humoral immune response following the third dose of BNT162b2 received by employees at a Slovak cancer healthcare facility"],"prefix":"10.3892","volume":"23","author":[{"given":"Patrik","family":"Palacka","sequence":"first","affiliation":[{"name":"2nd Department of Oncology, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Marusakova","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Central\u2011European Biotech Institute, 040 11 Kosice, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Rejlekova","sequence":"additional","affiliation":[{"name":"2nd Department of Oncology, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Svobodova","sequence":"additional","affiliation":[{"name":"Department of Outpatient Chemotherapy, National Cancer Institute, 833 10 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Skokanova","sequence":"additional","affiliation":[{"name":"Department of Outpatient Chemotherapy, National Cancer Institute, 833 10 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Vulganova","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Central\u2011European Biotech Institute, 040 11 Kosice, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Obertova","sequence":"additional","affiliation":[{"name":"2nd Department of Oncology, Faculty of Medicine, Comenius University, 833 10 Bratislava, Slovakia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"key20250611120257_b1-BR-23-1-01998"},{"key":"key20250611120257_b2-BR-23-1-01998"},{"key":"key20250611120257_b3-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"key20250611120257_b4-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"key20250611120257_b5-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJMoa2200674","article-title":"Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine","volume":"386","author":"Moreira","year":"2022","journal-title":"N Engl J Med"},{"key":"key20250611120257_b6-BR-23-1-01998","doi-asserted-by":"crossref","first-page":"293","DOI":"10.30714\/j-ebr.2020463629","article-title":"A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection","volume":"3","author":"Akta\u015f","year":"2020","journal-title":"Exp Biomed Res"},{"key":"key20250611120257_b7-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72 314 cases from the Chinese center for disease control and prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"key20250611120257_b8-BR-23-1-01998","first-page":"96","article-title":"Characteristics of Covid-19 infection with the original SARS-Cov-2 virus and other variants: A comparative review","volume":"2","author":"Aktas","year":"2022","journal-title":"J Bionic Mem"},{"key":"key20250611120257_b9-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1590\/1806-9282.67.Suppl1.20200678","article-title":"Hematological predictors of novel coronavirus infection","volume":"67 (Suppl 1)","author":"Aktas","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"key20250611120257_b10-BR-23-1-01998","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5114\/fmpcr.2022.113011","article-title":"Haemoglobin and red cell distribution width levels in internal medicine patients indicate recurrent hospital admission during COVID-19","volume":"24","author":"Atak","year":"2022","journal-title":"Fam Med Prim Care Rev"},{"key":"key20250611120257_b11-BR-23-1-01998","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5603\/DK.a2022.0015","article-title":"Frailty in diabetic subjects during Covid-19 and its association with HbA1c, mean platelet volume and monocyte\/lymphocyte ratio","volume":"11","author":"Atak","year":"2022","journal-title":"Clin Diabetol"},{"issue":"779453","key":"key20250611120257_b12-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779453","article-title":"Inflammation and platelet activation after COVID-19 vaccines-possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis","volume":"12","author":"Ostrowski","year":"2021","journal-title":"Front Immunol"},{"key":"key20250611120257_b13-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijid.2020.11.135","article-title":"Predictors and outcomes of healthcare-associated infections in COVID-19 patients","volume":"104","author":"Kumar","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"e90","key":"key20250611120257_b14-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2106599","article-title":"Effectiveness of mRNA Covid-19 vaccine among U.S. health care personnel","volume":"385","author":"Pilishvili","year":"2021","journal-title":"N Engl J Med"},{"key":"key20250611120257_b15-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1056\/NEJMc2101951","article-title":"BNT162b2 mRNA Covid-19 vaccine effectiveness among health care workers","volume":"384","author":"Benenson","year":"2021","journal-title":"N Engl J Med"},{"key":"key20250611120257_b16-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"1699.e5","DOI":"10.1016\/j.cmi.2021.06.043","article-title":"Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: An observational study using surveillance data","volume":"27","author":"Paris","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"key20250611120257_b17-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/S0140-6736(21)00790-X","article-title":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): A prospective, multicentre, cohort study","volume":"397","author":"Hall","year":"2021","journal-title":"Lancet"},{"key":"key20250611120257_b18-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"key20250611120257_b19-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","article-title":"Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: A systematic review and meta-regression","volume":"23","author":"Bobrovitz","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"e84","key":"key20250611120257_b20-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N Engl J Med"},{"issue":"558","key":"key20250611120257_b21-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040558","article-title":"Effectiveness, adverse events, and immune response following double vaccination with BNT162b2 in staff at the national comprehensive cancer center (NCCC)","volume":"10","author":"Palacka","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"key20250611120257_b22-BR-23-1-01998"},{"key":"key20250611120257_b23-BR-23-1-01998"},{"key":"key20250611120257_b24-BR-23-1-01998","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/01973533.2016.1277529","article-title":"Extracting the variance inflation factor and other multicollinearity diagnostics from typical regression results","volume":"39","author":"Thompson","year":"2017","journal-title":"Basic Appl Soc Psychol"},{"key":"key20250611120257_b25-BR-23-1-01998"},{"issue":"905585","key":"key20250611120257_b26-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.905585","article-title":"Nationwide effectiveness of first and second SARS-CoV2 booster vaccines during the delta and omicron pandemic waves in Hungary (HUN-VE 2 study)","volume":"13","author":"Kiss","year":"2022","journal-title":"Front Immunol"},{"issue":"1247129","key":"key20250611120257_b27-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1247129","article-title":"Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 delta variant in immunocompromised individuals","volume":"14","author":"Szekanecz","year":"2023","journal-title":"Front Immunol"},{"issue":"e0270801","key":"key20250611120257_b28-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270801","article-title":"Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia","volume":"17","author":"Berec","year":"2022","journal-title":"PLoS One"},{"key":"key20250611120257_b29-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"735.e1","DOI":"10.1016\/j.cmi.2022.01.019","article-title":"The effect of a third BNT162b2 vaccine on breakthrough infections in health care workers: A cohort analysis","volume":"28","author":"Oster","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"key20250611120257_b30-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"key20250611120257_b31-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.vaccine.2019.10.091","article-title":"Is there a difference in the immune response, efficacy, effectiveness and safety of seasonal influenza vaccine in males and females?-A systematic review","volume":"38","author":"Tadount","year":"2020","journal-title":"Vaccine"},{"issue":"233","key":"key20250611120257_b32-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020233","article-title":"Gender differences in adverse events following the Pfizer-BioNTech COVID-19 vaccine","volume":"10","author":"Green","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"key20250611120257_b33-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41564-021-00947-3","article-title":"Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom","volume":"6","author":"Wei","year":"2021","journal-title":"Nat Microbiol"},{"issue":"714","key":"key20250611120257_b34-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070714","article-title":"Antibodies responses to SARS-CoV-2 in a large cohort of vaccinated subjects and seropositive patients","volume":"9","author":"Amodio","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"153","key":"key20250611120257_b35-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10020153","article-title":"Decline of anti-SARS-CoV-2 IgG antibody levels 6 months after complete BNT162b2 vaccination in healthcare workers to levels observed following the first vaccine dose","volume":"10","author":"\u0110akovi\u0107 Rode","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1279","key":"key20250611120257_b36-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11051279","article-title":"Age, sex and BMI relations with anti-SARS-CoV-2-Spike IgG antibodies after BNT162b2 COVID-19 vaccine in health care workers in Northern Greece","volume":"11","author":"Papaioannidou","year":"2023","journal-title":"Microorganisms"},{"key":"key20250611120257_b37-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.cmi.2022.07.002","article-title":"Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses","volume":"28","author":"Braun","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"key20250611120257_b38-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.anai.2022.10.003","article-title":"Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273","volume":"130","author":"Ailsworth","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1508","key":"key20250611120257_b39-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121508","article-title":"Assessment of post-vaccination antibody response eight months after the administration of BNT1622b2 vaccine to healthcare workers with particular emphasis on the impact of previous COVID-19 infection","volume":"9","author":"Wolszczak-Biedrzycka","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"741","key":"key20250611120257_b40-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050741","article-title":"Anti-SARS-CoV-2S antibody levels in healthcare workers 10 months after the administration of two BNT162b2 vaccine doses in view of demographic characteristic and previous COVID-19 infection","volume":"10","author":"Wolszczak-Biedrzycka","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"key20250611120257_b41-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"7811","DOI":"10.2147\/IDR.S390351","article-title":"The influence of two priming doses of different anti-COVID-19 vaccines on the production of anti-SARS-CoV-2 antibodies after the administration of the Pfizer\/BioNTech booster","volume":"15","author":"Wolszczak Biedrzycka","year":"2022","journal-title":"Infect Drug Resist"},{"key":"key20250611120257_b42-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1080\/07853890.2023.2182907","article-title":"The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection","volume":"55","author":"Wolszczak-Biedrzycka","year":"2023","journal-title":"Ann Med"},{"key":"key20250611120257_b43-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4149\/BLL_2022_002","article-title":"Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19","volume":"123","author":"Sumbalova","year":"2022","journal-title":"Bratisl Lek Listy"},{"issue":"1085","key":"key20250611120257_b44-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3390\/v15051085","article-title":"Effect of vaccination on platelet mitochondrial bioenergy function of patients with post-acute COVID-19","volume":"15","author":"Gvozdj\u00e1kov\u00e1","year":"2023","journal-title":"Viruses"},{"key":"key20250611120257_b45-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/10408363.2022.2038539","article-title":"Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: A systematic review","volume":"59","author":"Notarte","year":"2022","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"640","key":"key20250611120257_b46-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00640","article-title":"Obesity, fat mass and immune system: Role for leptin","volume":"9","author":"Francisco","year":"2018","journal-title":"Front Physiol"},{"key":"key20250611120257_b47-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijid.2023.01.027","article-title":"Reduction of the risk of severe COVID-19 due to omicron compared to delta variant in Italy (November 2021-February 2022)","volume":"129","author":"Petrone","year":"2023","journal-title":"Int J Infect Dis"},{"key":"key20250611120257_b48-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1097\/MS9.0000000000000848","article-title":"Benefits and probable ill effects of WHO's declaration of end of COVID-19 pandemic: A way back to pandemic-free normal life","volume":"85","author":"Sarker","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"issue":"2632010X241228053","key":"key20250611120257_b49-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.1177\/2632010X241228053","article-title":"The WHO has declared COVID-19 is no longer a pandemic-level threat: A perspective evaluating potential public health impacts","volume":"17","author":"Roknuzzaman","year":"2024","journal-title":"Clin Pathol"},{"issue":"39","key":"key20250611120257_b50-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.1038\/s44298-024-00043-3","article-title":"Beyond COVID-19: The promise of next-generation coronavirus vaccines","volume":"2","author":"Koolaparambil Mukesh","year":"2024","journal-title":"NPJ Viruses"},{"issue":"125","key":"key20250611120257_b51-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00717-8","article-title":"Phase III pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin\u00ae)","volume":"8","author":"Singh","year":"2023","journal-title":"NPJ Vaccines"},{"key":"key20250611120257_b52-BR-23-1-01998","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41551-023-01094-2","article-title":"A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses","volume":"9","author":"Vishwanath","year":"2025","journal-title":"Nat Biomed Eng"},{"issue":"eabo2847","key":"key20250611120257_b53-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo2847","article-title":"An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination","volume":"15","author":"Carre\u00f1o","year":"2023","journal-title":"Sci Transl Med"},{"issue":"1051576","key":"key20250611120257_b54-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051576","article-title":"A novel mRNA vaccine, SYS6006, against SARS-CoV-2","volume":"13","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"issue":"466","key":"key20250611120257_b55-BR-23-1-01998","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01724-w","article-title":"Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period","volume":"8","author":"Ao","year":"2023","journal-title":"Signal Transduct Target Ther"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:03:24Z","timestamp":1749632604000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2025.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,20]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2025.1998","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"type":"print","value":"2049-9434"},{"type":"electronic","value":"2049-9442"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}